Company Info
Phone(212) 880-2060
Year Established
2004
Ticker
MSB
Exchange
ASX
Contacts
Silviu Itescu, Ph.D.CEO
Andrew Chaponnel
Interim CFO
Dagmar Rosa-Bjorkeson, MS, MBA
COO
Eric Rose, MD
CMO
Peter Howard, BSc, LLB (Hons)
General Counsel
Company Description
Mesoblast is committed to bringing to market innovative cellular medicines to treat serious and life-threatening diseases with significant, unmet medical needs.